EAGLE PHARMACEUTICALS, INC. Annual Interest Expense in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2022.
  • Eagle Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2023 was $1.45M, a 162% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2023 was $6.09M, a 256% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2022 was $4.05M, a 147% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2021 was $1.64M, a 36.6% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2020 was $2.58M, a 4.06% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.